gimli
CIPLA stock analysis context
CIPLA Stock Context for AI Screening
CIPLA LTD is a large-cap stock in Healthcare. This page summarizes key screening signals for CIPLA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about CIPLAPrice
₹1,399.20
1M return
+13.18%
3M return
+4.33%
Market cap
₹113,027.45 cr
PE
30.14
ROE
+12.91%
RSI
61.91
Turnover
₹128.35 cr
Why it can matter in screens
- Momentum: CIPLA is above 50DMA; RSI is 61.91.
- Returns: 1M +13.18%, 3M +4.33%, 6M -7.45%.
- Liquidity: latest turnover is ₹128.35 cr.
- Valuation: PE 30.14, PB 3.27, ROE +12.91%, ROCE +16.69%.
- Growth: 3Y sales CAGR +7.87%, 3Y profit CAGR +27.95%.
Try these prompts
- Analyze CIPLA with valuation, momentum and industry peers
- Compare CIPLA with other Healthcare stocks
- Show large-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View large-cap stocks
- Find stocks above 50DMA
- Compare CIPLA with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.